Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Sales | 0 | 299 | 20 | 20 | 20 |
| Gross Profit | N/A | 299 | 20 | 20 | 20 |
| Operating Expenses | 13,160 | 20,201 | 25,992 | 30,275 | 27,318 |
| Operating Income | -13,160 | -19,902 | -25,972 | -30,255 | -27,298 |
| Interest Expense | 385 | 776 | 787 | 780 | 826 |
| Other Income | 977 | -2,855 | -213 | 3,611 | -6,953 |
| Pre-tax Income | -12,568 | -23,533 | -26,972 | -27,424 | -35,077 |
| Net Income Continuous | -12,568 | -23,533 | -26,972 | -27,424 | -35,077 |
| Minority Interests | -46 | -51 | -52 | -47 | -53 |
| Net Income | $-12,522 | $-23,482 | $-26,920 | $-27,377 | $-35,024 |
| EPS Basic Total Ops | -6.50 | -24.00 | -21.00 | -16.51 | -26.99 |
| EPS Basic Continuous Ops | -5.30 | -10.60 | -13.51 | -14.67 | -19.96 |
| EPS Diluted Total Ops | -6.50 | -24.00 | -21.00 | -16.51 | -26.99 |
| EPS Diluted Continuous Ops | -5.30 | -10.60 | -13.51 | -14.67 | -19.96 |
| EBITDA(a) | $-12,713 | $-19,419 | $-25,489 | $-29,908 | $-26,822 |